Work

Suppression of Prostate Cancer Induced Bone Remodeling by The Endothelin Receptor a Antagonist Atrasentan

Year: 2003

Type: article

Study designs: Randomized Controlled Trial, Clinical Trial

Source: The Journal of Urology

DOI: 10.1097/01.ju.0000042162.08938.27

Authors: JOEL B. NELSON, AZMI A. NABULSI, NICHOLAS J. VOGELZANG, JURGEN BREUL, BERNARD A. ZONNENBERG, DANAI D. DALIANI, CLAUDE C. SCHULMAN, MICHAEL A. CARDUCCI

Institutions: Johns Hopkins University, Johns Hopkins Medicine, TUM Klinikum, University Medical Center Utrecht, University of Chicago, University of Chicago Medical Center, Sidney Kimmel Comprehensive Cancer Center

Language: English

Topic: Bone health and treatments

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

Funders: National Institutes of Health, National Cancer Institute

Awards: G1391097410, GENE THERAPY FOR PROSTATE CANCER, G494716145, Cancer Center Support Grant

OpenAlex ID: W2085960871

FWCI: 9.161

Cites: 22

Cited by: 137

Related to: 10